| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |